Emilio Francesco Giunta - Dept Precis Med, Univ Campania Luigi Vanvitelli

基本信息

Career Trajectory

Bio

I'm a Medical Oncologist, currently working at IRST of Meldola (director: Dr U De Giorgi), and a PhD student in Translational Medicine at University of Campania Vanvitelli. I attended for 5 years the residency in Medical Oncology at the University of Campania Vanvitelli (tutors: Prof T Troiani and Prof F Ciardiello), focusing on CRC and melanoma. I attended also a clinical fellowship at the GIRT-Uro Unit at the Candiolo Cancer Institute (tutor Dr P Rescigno) focusing on urological cancers.

Research Interests

Papers共 95 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

LBA71 Open-label, Multicentre Randomised Trial of Radium223-docetaxel Versus Docetaxel-Radium223 Sequence in Metastatic Castration Resistant Prostate Cancer (mcrpc) with Prospective Biomarker Evaluation (RAPSON Study)

V. Conteduca,N. Brighi,G. Gurioli,D. Wetterskog,E.F. Giunta,C. Lolli,G. Schepisi,V.E. Chiuri, D. Gasparro, P.A. Zucali,A. Virga, I. Bondi,B. Vertogen,V. Di Iorio,M. Sansovini, S. Severi, E. Scarpi,M. Urbini, G. Attard, U. De Giorgi

Annals of Oncology (2024)

Cited0Views0Bibtex

Lipidomic Profiling As a Biomarker for Prostate Cancer Diagnosis and Response to Enzalutamide (Enza)

Sara Bleve,Francesco Ravera,Silvia Rodrigues, Mohamed Omar,Emilio Francesco Giunta,Filippo Pederzoli,Hubert Pakula,Amelia Altavilla,Nicole Brighi, Giorgia Gurioli,Maria Concetta Cursano,Chiara Casadei,Cristian Lolli,Giuseppe Schepisi,David M. Nanus,Pier Vitale Nuzzo,Ugo De Giorgi,Massimo Loda

JOURNAL OF CLINICAL ONCOLOGYno. 4_SUPPL (2024): 217-217

Cited0Views0Bibtex

A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: is There Still a Role for Chemotherapy

Lorenzo Gasperoni,Luna Del Bono,Andrea Ossato,Emilio Francesco Giunta,Andrea Messori,Vera Damuzzo

CANCERSno. 13 (2024)

Cited0Views0WOSBibtex

New-generation Androgen Receptor Signaling Inhibitors (arsis) in Metastatic Hormone-Sensitive Prostate Cancer (mhspc): Pharmacokinetics, Drug-Drug Interactions (ddis), and Clinical Impact

Lorenzo Gasperoni,Emilio Francesco Giunta,Daniela Montanari,Carla Masini,Ugo De Giorgi

Expert opinion on drug metabolism & toxicologypp.1-12, (2024)

Cited0Views0WOSBibtex

177Lu-Psma Therapy in Metastatic Prostate Cancer: an Updated Review of Prognostic and Predictive Biomarkers

Emilio Francesco Giunta,Nicole Brighi,Giorgia Gurioli,Federica Matteucci,Giovanni Paganelli,Ugo De Giorgi

Cancer treatment reviews (2024): 102699-102699

Cited0Views0WOSBibtex

Neoadjuvant Chemo-Immunotherapy for Early-Stage Non-Small Cell Lung Cancer A Systematic Review and Meta-Analysis

Giuseppe Luigi Banna,Mona Ali Hassan,Alessio Signori,Emilio Francesco Giunta,Akash Maniam,Shobana Anpalakhan,Shyamika Acharige,Aruni Ghose,Alfredo Addeo

JAMA NETWORK OPENno. 4 (2024)

Cited0Views0WOSBibtex

Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis

Carlo Messina,Emilio Francesco Giunta,Alessio Signori,Sara Elena Rebuzzi,Giuseppe Luigi Banna,Akash Maniam,Sebastiano Buti,Carlo Cattrini,Giuseppe Fornarini,Matteo Bauckneht,Alastair Greystoke,Ruth Plummer,Christoph Oing,Pasquale Rescigno

EUROPEAN UROLOGY ONCOLOGY（2024）

Cited3Views0WOSBibtex

Pharmacological Treatment Landscape of Non-Metastatic Hormone-Sensitive Prostate Cancer: a Narrative Review on Behalf of the Meet-URO Group

Emilio Francesco Giunta,Giandomenico Roviello,Vincenza Conteduca,Elena Verzoni,Giuseppe Procopio,Ugo De Giorgi

Critical reviews in oncology/hematology (2024): 104534-104534

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn